v3.26.1
Condensed consolidated statements of stockholders' equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2024 $ 229,021 $ 5 $ 719,997 $ (151) $ (490,830)
Balance, Shares at Dec. 31, 2024   54,032,826      
Unrealized gain (loss) on marketable securities 47     47  
Stock-based compensation 6,753   6,753    
Issuance of common stock upon exercise of stock options 1,004   1,004    
Issuance of common stock upon exercise of stock options, Shares   214,996      
Issuance of common stock related to employee stock purchase plan 370   370    
Issuance of common stock related to employee stock purchase plan, Shares   39,467      
Issuance of vested restricted stock units and performance stock units, Shares   308,425      
Net Income (Loss) 112,879       112,879
Balance at Mar. 31, 2025 350,074 $ 5 728,124 (104) (377,951)
Balance, Shares at Mar. 31, 2025   54,595,714      
Balance at Dec. 31, 2024 229,021 $ 5 719,997 (151) (490,830)
Balance, Shares at Dec. 31, 2024   54,032,826      
Unrealized gain (loss) on marketable securities 247        
Net Income (Loss) 89,397        
Balance at Jun. 30, 2025 334,943 $ 5 736,276 96 (401,434)
Balance, Shares at Jun. 30, 2025   54,723,455      
Balance at Mar. 31, 2025 350,074 $ 5 728,124 (104) (377,951)
Balance, Shares at Mar. 31, 2025   54,595,714      
Unrealized gain (loss) on marketable securities 200     200  
Stock-based compensation 7,598   7,598    
Issuance of common stock upon exercise of stock options 554   554    
Issuance of common stock upon exercise of stock options, Shares   126,531      
Issuance of vested restricted stock units and performance stock units, Shares   1,210      
Net Income (Loss) (23,483)       (23,483)
Balance at Jun. 30, 2025 334,943 $ 5 736,276 96 (401,434)
Balance, Shares at Jun. 30, 2025   54,723,455      
Balance at Dec. 31, 2025 352,457 $ 5 849,624 543 (497,715)
Balance, Shares at Dec. 31, 2025   58,921,999      
Unrealized gain (loss) on marketable securities (658)     (658)  
Stock-based compensation 8,753   8,753    
Issuance of common stock upon exercise of stock options 3,205   3,205    
Issuance of common stock upon exercise of stock options, Shares   260,554      
Issuance of common stock related to employee stock purchase plan 465   465    
Issuance of common stock related to employee stock purchase plan, Shares   46,994      
Issuance of vested restricted stock units and performance stock units, Shares   443,786      
Shares sold as part of controlled equity offering sales agreement 80,658 $ 1 80,657    
Shares sold as part of controlled equity offering sales agreement, Shares   2,567,014      
Net Income (Loss) (50,003)       (50,003)
Balance at Mar. 31, 2026 394,877 $ 6 942,704 (115) (547,718)
Balance, Shares at Mar. 31, 2026   62,240,347      
Balance at Dec. 31, 2025 352,457 $ 5 849,624 543 (497,715)
Balance, Shares at Dec. 31, 2025   58,921,999      
Unrealized gain (loss) on marketable securities (1,085)        
Net Income (Loss) (111,621)        
Balance at Jun. 30, 2026 345,547 $ 6 955,419 (542) (609,336)
Balance, Shares at Jun. 30, 2026   62,402,595      
Balance at Mar. 31, 2026 394,877 $ 6 942,704 (115) (547,718)
Balance, Shares at Mar. 31, 2026   62,240,347      
Unrealized gain (loss) on marketable securities (427)     (427)  
Stock-based compensation 10,802   10,802    
Issuance of common stock upon exercise of stock options 1,913   1,913    
Issuance of common stock upon exercise of stock options, Shares   162,248      
Net Income (Loss) (61,618)       (61,618)
Balance at Jun. 30, 2026 $ 345,547 $ 6 $ 955,419 $ (542) $ (609,336)
Balance, Shares at Jun. 30, 2026   62,402,595